T cell activation and anti-tumor efficacy of anti-Lag3 mAbs are independent of Lag-3–MHC Class II blocking capacity by De Waal Malefyt, R, Zhao, S, Haines, B, Chenard, M, Laskey, J, Cui, L, Blumenschein, W, Churakova, T, Shukla, R, Hsieh, E, Beaumont, M, Fayadat-Dilman, L, Cemerski, S

Get full text

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells by Brandish, Philip E, Palmieri, Anthony, Antonenko, Svetlana, Beaumont, Maribel, Benso, Lia, Cancilla, Mark, Cheng, Mangeng, Fayadat-Dilman, Laurence, Feng, Guo, Figueroa, Isabel, Firdos, Juhi, Garbaccio, Robert, Garvin-Queen, Laura, Gately, Dennis, Geda, Prasanthi, Haines, Christopher, Hseih, SuChun, Hodges, Douglas, Kern, Jeffrey, Knudsen, Nickolas, Kwasnjuk, Kristen, Liang, Linda, Ma, Huiping, Manibusan, Anthony, Miller, Paul L, Moy, Lily Y, Qu, Yujie, Shah, Sanjiv, Shin, John S, Stivers, Peter, Sun, Ying, Tomazela, Daniela, Woo, Hyun Chong, Zaller, Dennis, Zhang, Shuli, Zhang, Yiwei, Zielstorff, Mark

Get full text

Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis by Chao, Cheng-Chi, Chen, Shi-Juan, Adamopoulos, Iannis E., Davis, Nicole, Hong, Kyu, Vu, Anna, Kwan, Sylvia, Fayadat-Dilman, Laurence, Asio, Agelio, Bowman, Edward P.

Get full text

298 - T cell activation and anti-tumor efficacy of anti-Lag3 mAbs are independent of Lag-3–MHC Class II blocking capacity by De Waal Malefyt, R., Zhao, S., Haines, B., Chenard, M., Laskey, J., Cui, L., Blumenschein, W., Churakova, T., Shukla, R., Hsieh, E., Beaumont, M., Fayadat-Dilman, L., Cemerski, S.

Get full text

Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions by Lai, Pin-Kuang, Ghag, Gaurav, Yu, Yao, Juan, Veronica, Fayadat-Dilman, Laurence, Trout, Bernhardt L

Get full text

Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action by Palte, Rachel L., Juan, Veronica, Gomez-Llorente, Yacob, Bailly, Marc Andre, Chakravarthy, Kalyan, Chen, Xun, Cipriano, Daniel, Fayad, Ghassan N., Fayadat-Dilman, Laurence, Gathiaka, Symon, Greb, Heiko, Hall, Brian, Handa, Mas, Hsieh, Mark, Kofman, Esther, Lin, Heping, Miller, J. Richard, Nguyen, Nhung, O’Neil, Jennifer, Shaheen, Hussam, Sterner, Eric, Strickland, Corey, Sun, Angie, Taremi, Shane, Scapin, Giovanna

Get full text

Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action by Palte, Rachel L., Juan, Veronica, Gomez-Llorente, Yacob, Bailly, Marc Andre, Chakravarthy, Kalyan, Chen, Xun, Cipriano, Daniel, Fayad, Ghassan N., Fayadat-Dilman, Laurence, Gathiaka, Symon, Greb, Heiko, Hall, Brian, Handa, Mas, Hsieh, Mark, Kofman, Esther, Lin, Heping, Miller, J. Richard, Nguyen, Nhung, O’Neil, Jennifer, Shaheen, Hussam, Sterner, Eric, Strickland, Corey, Sun, Angie, Taremi, Shane, Scapin, Giovanna

Get full text

Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab by Hutchins, Beth, Starling, Gary C, McCoy, Mark A, Herzyk, Danuta, Poulet, Frederique M, Dulos, John, Liu, Liming, Kang, Soonmo Peter, Fayadat-Dilman, Laurence, Hsieh, Mark, Andrews, Christine L, Ayanoglu, Gulesi, Cullen, Constance, Malefyt, Rene de Waal, Kastelein, Robert A, Saux, Sabine Le, Lee, Julie, Li, Sophie, Malashock, Dan, Sadekova, Svetlana, Soder, George, van Eenennaam, Hans, Willingham, Aarron, Yu, Ying, Streuli, Michel, Carven, Gregory J, van Elsas, Andrea

Get full text

Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions by Lai, Pin-Kuang, Ghag, Gaurav, Yu, Yao, Juan, Veronica, Fayadat-Dilman, Laurence, Trout, Bernhardt L.

Get full text